Mark Lambermon
-
Defence Therapeutics Appoints Mark Lambermon as Head of Quality and Operations
Defence Therapeutics appointed Dr. Mark Lambermon as Head of Quality and Operations to advance its Accum® technology. Dr. Lambermon brings over 20 years of pharmaceutical experience from companies like AbbVie and Baxter, specializing in GMP-compliant quality systems and CMC programs. His role will be crucial in scaling operations, ensuring regulatory readiness, and supporting strong pharma partnerships as Defence progresses with Accum®, which aims to enhance targeted delivery of Antibody-Drug Conjugates (ADCs). He received 100,000 immediately vested stock options.